surmount study tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Adverse effects: Orlistat-associated to liver failure Orlistat, a drug inhibiting pancreatic lipase and aimed at aiding weight loss, has been linked to severe liver-related side effects, including the formation of gallstones, liver inflammation with bile obstruction, and acute liver failure, as highlighted in various studies [5, 42, 66,67,68,69]

Mol Endocrinol (1996) 10(4):34255

A patient reads two headlines on the same day: one drug delivered 24% weight loss in a trial, the other is sitting in a pharmacy fridge right now

Semaglutide A GLP-1 receptor agonist used in FDA-approved medications for diabetes and chronic weight management under specific brand names and indications